Why I Pioneer
We are Flagship Pioneering
We invent platforms and build companies that change the world.
Pioneering Partnerships
GSK and Flagship Pioneering partner to discover novel medicines and vaccines
Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World
Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer
Valo Health and Novo Nordisk Expand Collaboration to Discover and Develop Novel Treatments for Cardiometabolic Diseases
Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
Our Companies
- Moderna Founded: 2010
- Tessera Therapeutics Founded: 2018
- Generate:Biomedicines Founded: 2018
- Inari Agriculture Founded: 2016
- Quotient Therapeutics Founded: 2022
Latest News
- Repertoire® Immune Medicines Enters into Collaboration and License Agreement with Genentech for the Development of T cell-Targeted Therapies for an Autoimmune Disease 04.23.2025
- Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease 04.01.2025
- Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science 03.10.2025
- Flagship Pioneering Appoints Paul Owen as CEO-Partner and CEO of YourBio Health 02.19.2025
- Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation 01.23.2025
- Valo Health and Novo Nordisk Expand Collaboration to Discover and Develop Novel Treatments for Cardiometabolic Diseases 01.08.2025
Employee Spotlight
Off the Clock with Flagship Employees
Life Illustrated: Lovisa Afzelius
Companies founded
100+
Special Section
